Associação do subnitrato de bismuto a terapia omeprazol e amoxacilina na erradicação do Helicobacter pylori
AUTOR(ES)
Luiz Antonio Fiorelli
DATA DE PUBLICAÇÃO
1998
RESUMO
To evaluate whether the addition ofbismuth subnitrate to a dual oral therapy (DOT) regimen with omeprazole plus amoxicillin could improveHelicobacter pylori eradication. Fifty consecutive Helicobacter pylori positive patients were randomly enrolled to receive either (A) bismuth subnitrate (300 mg q.i.d.), omeprazole (20 mg q.i.d.) and amoxicillin (500 mg q.i.d.), or (B) omeprazole (20 mg q.i.d.) and amoxicillin (500 mg q.i.d.). Both groups (n=25 each) received the medication for 2 weeks. Helicobacter pylori status was reassessed 30 days following completion of the therapy in order Six patients were lost to follow up and therefore exc1eded from the study (3 patients from each group). One patient from Group B withdrew the study because of side effects. Ther addition of bismuth subnitrate to on1eprazole and amoxicillin significantly improved its efficacy in to evaluate eradication rates. eradicating Helicobacter pylori, with 72% (18/25) eradication in group A and 52% (13/25) ingroup B (p=0.027). The addition ofbismuth subnitrate to DOT was also capable of improving the healing of peptic. ulcers when compared with DOT alone (100%,8/8 vs. 58%,4/7; p=0.02l). Our results demonstrate that the association of bismuth subnitrate to DOT enhances Helicobacter pylori eradication, and improves healing of peptic ulcers
ASSUNTO(S)
biopsia epidemiologia helicobacter pylori
ACESSO AO ARTIGO
http://libdigi.unicamp.br/document/?code=vtls000186847Documentos Relacionados
- Terapia tríplice com claritromicina, amoxicilina e omeprazol para erradicação do Helicobacter pylori em crianças e adolescentes
- Furazolidona, tetraciclina e omeprazol: uma alternativa de baixo custo para erradicação de Helicobacter pylori em crianças
- Eficácia do regime terapêutico empregando a associação de pantoprazol, claritromicina e amoxicilina, durante uma semana, na erradicação do Helicobacter pylori em pacientes com úlcera péptica
- Baixa eficácia de um tratamento tríplice de curta duração, em dose única diária, para erradicação do Helicobacter pylori em pacientes ulcerosos com Omeprazol, Azitromicina e Secnidazol
- Omeprazol, Tetraciclina e Furazolidona, um tratamento para erradicação do H. pylori resistente em pacientes ulcerosos do Brasil